| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Advances in Brief |
Department of Medicine, University of Okayama [K. Na., F. I., H. D., K. Matsuo, K. F., N. S., H. N., K. T., K. S., K. Ik., K. Ni., M. Harad.], Okayama Rousai Hospital [T. Y.], National Okayama Hospital [S. F.], Okayama Municipal Hospital [K. Im.], and National Sanatorium Minami Okayama Hospital [M. T.], Okayama 700-8558, Japan; Chugoku Central Hospital of the Mutual Aid Association of Public School Teachers, Fukuyama 721-0975, Japan [A. M.]; Ehime Prefectural Central Hospital [M. Hara], Department of Medicine, University of Ehime [M. Y.], Ehime 791-0295, Japan; Kochi Municipal Central Hospital [I. T.], Department of Medicine, Kochi Medical School [H. T.], Kochi 783-8505, Japan; Kameda General Hospital, Kamogawa 296-0041, Japan [K. Matsue]; Department of Medicine, University of Kanazawa, Kanazawa 920-8641, Japan [S. N.]; Department of Medicine, University of Kyushu, Fukuoka 812-8582, Japan [Y. N.]; and Cutaneous Biology Research Center, Massachusetts General Hospital, Charlestown, Massachusetts 02129 [N. A.]
Gene targeting studies in mice have shown that the transcription factor Ikaros plays an essential role in lymphoid development and as a tumor suppressor in T cells, whereas the related gene Aiolos functions as a tumor suppressor in B cells. We analyzed the expression levels of the Ikaros gene family, Ikaros and Aiolos, in human bone marrow samples from patients with adult acute lymphoblastic leukemia [ALL (n = 46; B-cell ALL = 41; T-cell ALL = 5)]. Overexpression of the dominant negative isoform of Ikaros gene Ik-6 was observed in 14 of 41 B-cell ALL patients by reverse transcription-PCR, and the results were confirmed by sequencing analysis and immunoblotting. None of the other dominant negative isoforms of the Ikaros gene were detected by reverse transcription-PCR analysis. Southern blotting analysis with PstI digestion revealed that those patients with the dominant negative isoform Ik-6 might have small mutations in the Ikaros locus. We did not detect any overexpression of dominant negative isoforms of Aiolos in adult ALL patients. These results suggest that Ikaros plays a key role in human B-cell malignancies through the dominant negative isoform Ik-6.
This article has been cited by other articles:
|
|
 |
|
  S. Loeper, S. L. Asa, and S. Ezzat Ikaros Modulates Cholesterol Uptake: A Link between Tumor Suppression and Differentiation Cancer Res., May 15, 2008; 68(10): 3715 - 3723. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Antica, L. Cicin-Sain, S. Kapitanovic, M. Matulic, S. Dzebro, and M. Dominis Aberrant Ikaros, Aiolos, and Helios expression in Hodgkin and non-Hodgkin lymphoma Blood, March 15, 2008; 111(6): 3296 - 3297. [Full Text] [PDF]
|
|
|
|
|
|
Z. Zhang, C. S. Swindle, J. T. Bates, R. Ko, C. V. Cotta, and C. A. Klug Expression of a non-DNA-binding isoform of Helios induces T-cell lymphoma in mice Blood, March 1, 2007; 109(5): 2190 - 2197. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Ezzat, R. Mader, S. Fischer, S. Yu, C. Ackerley, and S. L. Asa An essential role for the hematopoietic transcription factor Ikaros in hypothalamic-pituitary-mediated somatic growth PNAS, February 14, 2006; 103(7): 2214 - 2219. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Dumortier, R. Jeannet, P. Kirstetter, E. Kleinmann, M. Sellars, N. R. dos Santos, C. Thibault, J. Barths, J. Ghysdael, J. A. Punt, et al. Notch Activation Is an Early and Critical Event during T-Cell Leukemogenesis in Ikaros-Deficient Mice Mol. Cell. Biol., January 1, 2006; 26(1): 209 - 220. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. P. Tschan, K. M. Fischer, V. S. Fung, F. Pirnia, M. M. Borner, M. F. Fey, A. Tobler, and B. E. Torbett Alternative Splicing of the Human Cyclin D-binding Myb-like Protein (hDMP1) Yields a Truncated Protein Isoform That Alters Macrophage Differentiation Patterns J. Biol. Chem., October 31, 2003; 278(44): 42750 - 42760. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. J. Payne, G. Huang, E. Sahakian, J. Y. Zhu, N. S. Barteneva, L. W. Barsky, M. A. Payne, and G. M. Crooks Ikaros Isoform X Is Selectively Expressed in Myeloid Differentiation J. Immunol., March 15, 2003; 170(6): 3091 - 3098. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. M. Thomas, K. Haleem, A. B. Siddique, W. J. Simmons, N. Sen, D.-J. Zhang, and V. K. Tsiagbe Regulation of Mouse Mammary Tumor Virus env Transcriptional Activator Initiated Mammary Tumor Virus Superantigen Transcripts in Lymphomas of SJL/J Mice: Role of Ikaros, Demethylation, and Chromatin Structural Change in the Transcriptional Activation of Mammary Tumor Virus Superantigen J. Immunol., January 1, 2003; 170(1): 218 - 227. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Nishii, N. Katayama, and H. Shiku Adult acute myeloid leukemia cells do not express nonfunctional Ikaros isoforms Blood, October 16, 2002; 100(9): 3436 - 3436. [Full Text] [PDF]
|
|
|
|
|
|
F. Ishimaru, T. Yagi, S. Hibi, M. Takanashi, G. Kano, Y. Tabata, T. Imamura, T. Inaba, A. Morimoto, S. Todo, et al. Expression of Ikaros isoforms in patients with acute myeloid leukemia Blood, July 30, 2002; 100(4): 1511 - 1513. [Full Text] [PDF]
|
|
|
|
|
|
A. Karlsson, P. Soderkvist, and S.-M. Zhuang Point Mutations and Deletions in the Znfn1a1/Ikaros Gene in Chemically Induced Murine Lymphomas Cancer Res., May 1, 2002; 62(9): 2650 - 2653. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
